XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH
about
Mouse DNA contamination in human tissue tested for XMRVNo evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitroIn-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancerNo evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohortInvestigation into the presence of and serological response to XMRV in CFS patientsLack of detection of XMRV in seminal plasma from HIV-1 infected men in The NetherlandsThe xenotropic murine leukemia virus-related retrovirus debate continues at first international workshopNew insights into the role of RNase L in innate immunityDisease-associated XMRV sequences are consistent with laboratory contaminationAnalysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infectionNo evidence of XMRV in prostate cancer cohorts in the Midwestern United StatesXMRV: a new virus in prostate cancer?XMRV and prostate cancer--a 'final' perspectiveCrystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease HCharacterization, mapping, and distribution of the two XMRV parental provirusesXenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task forceNo difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controlsEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromeAbsence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patientsXenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cellsAntibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model.No association of xenotropic murine leukemia virus-related viruses with prostate cancer.No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern EuropeAbsence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States.Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies.Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses.Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.Recombinant origin, contamination, and de-discovery of XMRVPCR master mixes harbour murine DNA sequences. Caveat emptor!Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells.Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRVPhylogenetic analysis of murine leukemia virus sequences from longitudinally sampled chronic fatigue syndrome patients suggests PCR contamination rather than viral evolution.In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteinsBiochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq.Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.
P2860
Q21093226-1B50F095-3B23-4A4F-A483-86E2008E6509Q21135591-EF1DC2EE-906B-4164-B523-5A44D6A9D9E0Q21560763-178C38AF-E526-4CBB-89C6-7D8D4840A634Q21560843-5F00372B-5AAE-4CA1-A94F-EFBE6740EF30Q21560846-5B99794C-92E1-479C-85A1-24E13992FEA3Q21562183-386E57F6-6C45-480B-8E80-5AA406129982Q24595372-07A57314-9B6B-4DA8-AEE6-EB19C82D01BDQ24597466-753912F3-CE11-4FBB-AF2B-E8269CD59D92Q24602555-EB529C5F-C7E2-4D64-8DDD-BD9549CFAEF8Q24606155-26333E0D-2C35-4B73-BB36-C40EFF908D88Q24615054-79489FF2-A631-47C8-96C5-4B2C2F8F3EA7Q24626672-0C68B446-D8BB-4BD7-8DDC-99A856FD92B9Q27010480-C218A2A6-66F5-4E76-8FBC-529F6CEC56BCQ27681320-85E96B61-1447-4663-A9E1-12F4EDB6A37FQ28251595-E8E415A4-BA8C-4C94-8D6E-46DDF30452FBQ28303254-D23C7E14-8E4F-4593-9F8D-1DA61E0689E1Q28304351-14326B62-7DC9-462D-81C5-F9B1A7640F5CQ28304673-2F8BF93A-D2C3-425A-ACA2-5A85FB3043A2Q28729913-181549D5-349A-4ACC-AF03-C11335269E5CQ28729917-8CF2C104-48B2-4DB5-843B-A97A231BB37FQ30249212-9312D827-7089-494A-813E-49D35E52E27FQ33561543-F897B673-3CC3-4BC3-9B1A-C624F815CC2BQ33873719-F18005F8-DA31-4B86-88D6-786564968464Q33900919-8D8088AD-4727-4BD7-8237-4A1C468C3807Q34055653-00A38CDE-1D6F-4397-96B1-A4F5B1054EEFQ34081515-1408BF21-74C4-4375-B97E-5C8904A84AA1Q34097739-E7EF06D9-10A8-4A9A-BBFA-4076EA9DACD2Q34128479-E81CE4A5-15E2-40ED-9FB7-7270AA5816C9Q34163532-B56CE228-377C-45E5-8B7B-1FB7B3D9500FQ34217810-0FFB8A3B-B369-4815-B04B-734DEB2BF8C1Q34278035-CE7F1CF9-73BB-4AF3-AAF1-833AA8931819Q34289436-2C8C8B67-929E-4A24-8357-F743B600C2E8Q35007361-ED0A4DD2-1AFE-4551-898F-216EB69C8797Q35076674-CF7429A4-B6DA-4C94-B1FF-0EF833C3B9E3Q35076851-4972446E-ED72-4A14-9AA6-E7DE6AAA9CE4Q35275100-EF5456C8-C30E-4976-BBA4-09B6AF588966Q35529276-8D553880-63D8-4303-817A-894479C986C5Q35633587-6D356E1E-2433-4A8D-B31A-003518EB4222Q35656247-E9C25868-DF88-4015-A929-90C8857371B9Q35692305-A53D6607-5D65-497F-83A0-929AC9AC1661
P2860
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
XMRV infection in patients wit ...... correlation with PCR and FISH
@ast
XMRV infection in patients wit ...... correlation with PCR and FISH
@en
XMRV infection in patients wit ...... correlation with PCR and FISH
@nl
type
label
XMRV infection in patients wit ...... correlation with PCR and FISH
@ast
XMRV infection in patients wit ...... correlation with PCR and FISH
@en
XMRV infection in patients wit ...... correlation with PCR and FISH
@nl
prefLabel
XMRV infection in patients wit ...... correlation with PCR and FISH
@ast
XMRV infection in patients wit ...... correlation with PCR and FISH
@en
XMRV infection in patients wit ...... correlation with PCR and FISH
@nl
P2093
P1433
P1476
XMRV infection in patients wit ...... correlation with PCR and FISH
@en
P2093
Adeboye O Osunkoya
Dennis Liotta
Eric Hunter
Fray F Marshall
Jerry L Blackwell
John A Petros
Natalia V Makarova
Nicole A Johnson
Rebecca S Arnold
P304
P356
10.1016/J.UROLOGY.2010.01.038
P407
P577
2010-04-01T00:00:00Z